Marinus (MRNS) Reiterated at Outperform by Cowen, RAISE Delay is Unfortunate, but Shares Undervalued on ganaxolone Potential
Tweet Send to a Friend
Cowen analyst Joseph Thome reiterated an Outperform rating on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
